BMPR2 and pulmonary arterial hypertension: Studies have indicated that inflammation or endotoxin is a trigger point for BMPR-II to cause PAH and have demonstrated that the deficiency of BMPR-II exhibits a proinflammatory phenotype that leads to pulmonary vascular remodeling [47].